SU9518 inhibits proliferative vitreoretinopathy in fibroblast and genetically modified Müller cell-induced rabbit models

Investigative Ophthalmology and Visual Science

Volumn 54, Issue 2, 2013, Pages 1392-1397

  Velez, Gisela ^a   Weingarden, Alexa R ^b   Lei, Hetian ^b   Kazlauskas, Andrius ^b   Gao, Guangping ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3[5 (5 BROMO 2 OXO 1,2 DIHYDROINDOL 3 YLIDENEMETHYL) 2,4 DIMETHYL 1H PYRROL 3 YL]PROPIONIC ACID; PLATELET DERIVED GROWTH FACTOR ALPHA RECEPTOR; PROTEIN TYROSINE KINASE INHIBITOR; SU 9518; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; DRUG HALF LIFE; FIBROBLAST; HUMAN; HUMAN CELL; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; MUELLER CELL; NONHUMAN; OPHTHALMOSCOPY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RABBIT; RETINA DETACHMENT; VITREORETINOPATHY; WESTERN BLOTTING;

ANIMALS; CELL DIVISION; CELLS, CULTURED; DISEASE MODELS, ANIMAL; FIBROBLASTS; HUMANS; INDOLES; RABBITS; RECEPTORS, PLATELET-DERIVED GROWTH FACTOR; RETINAL PIGMENT EPITHELIUM; VITREORETINOPATHY, PROLIFERATIVE; VITREOUS BODY;

EID: 84874999581     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.12-10320     Document Type: Article

References (24)

1. Zilis JD, Machemer R. Light damage in detached retina. Am J Ophthalmol. 1991;111:47-50.
2. Fisher SK, Erickson PA, Lewis GP, Anderson DH. Intraretinal proliferation induced by retinal detachment. Invest Ophthalmol Vis Sci. 1991;32:1739-1748.
3. Lewis GP, Charteris DG, Sethi CS, Leitner WP, Linberg KA, Fisher SK. The ability of rapid retinal reattachment to stop or reverse the cellular and molecular events initiated by detachment. Invest Ophthalmol Vis Sci. 2002;43:2412-2420.
4. Weller M, Wiedemann P, Heimann K. Proliferative vitreoretinopathy-is it anything more than wound healing at the wrong place? Int Ophthalmol. 1990;14:105-117.
5. Luna G, Lewis GP, Banna CD, Skalli O, Fisher SK. Expression profiles of nestin and synemin in reactive astrocytes and Muller cells following retinal injury: a comparison with glial fibrillar acidic protein and vimentin. Mol Vis. 2010;16:2511-2523.
6. Guidry C, King JL, Mason JO 3rd. Fibrocontractive Muller cell phenotypes in proliferative diabetic retinopathy. Invest Ophthalmol Vis Sci. 2009;50:1929-1939.
7. Okada M, Matsumura M, Ogino N, Honda Y. Muller cells in detached human retina express glial fibrillary acidic protein and vimentin. Graefes Arch Clin Exp Ophthalmol. 1990;228: 467-474.
8. Lewis GP, Guerin CJ, Anderson DH, Matsumoto B, Fisher SK. Rapid changes in the expression of glial cell proteins caused by experimental retinal detachment. Am J Ophthalmol. 1994; 118:368-376.
9. Geller SF, Lewis GP, Anderson DH, Fisher SK. Use of the MIB-1 antibody for detecting proliferating cells in the retina. Invest Ophthalmol Vis Sci. 1995;36:737-744.
10. Lewis GP, Chapin EA, Luna G, Linberg KA, Fisher SK. The fate of Muller's glia following experimental retinal detachment: nuclear migration, cell division, and subretinal glial scar formation. Mol Vis. 2010;16:1361-1372.
11. Robbins SG, Mixon RN, Wilson DJ, et al. Platelet-derived growth factor ligands and receptors immunolocalized in proliferative retinal diseases. Invest Ophthalmol Vis Sci. 1994;35:3649-3663.
12. Cui J, Lei H, Samad A, et al. PDGF receptors are activated in human epiretinal membranes. Exp Eye Res. 2009;88:438-444.
13. Andrews A, Balciunaite E, Leong FL, et al. Platelet-derived growth factor plays a key role in proliferative vitreoretinopathy. Invest Ophthalmol Vis Sci. 1999;40:2683-2689.
14. Ikuno Y, Kazlauskas A. An in vivo gene therapy approach for experimental proliferative vitreoretinopathy using the truncated platelet-derived growth factor alpha receptor. Invest Ophthalmol Vis Sci. 2002;43:2406-2411.
15. Zheng Y, Ikuno Y, Ohj M, et al. Platelet-derived growth factor receptor kinase inhibitor AG1295 and inhibition of experimental proliferative vitreoretinopathy. Jpn J Ophthalmol. 2003;47:158-165.
16. Lei H, Velez G, Cui J, et al. N-acetylcysteine suppresses retinal detachment in an experimental model of proliferative vitreoretinopathy. Am J Pathol. 2010;177:132-140.
17. Limb GA, Salt TE, Munro PM, Moss SE, Khaw PT. In vitro characterization of a spontaneously immortalized human Muller cell line (MIO-M1). Invest Ophthalmol Vis Sci. 2002; 43:864-869.
18. Fastenberg DM, Diddie KR, Delmage JM, Dorey K. Intraocular injection of silicone oil for experimental proliferative vitreoretinopathy. Am J Ophthalmol. 1983;95:663-667.
19. Velez G, Weingarden AR, Tucker BA, Lei H, Kazlauskas A, Young MJ. Retinal pigment epithelium and Muller progenitor cell interaction increase Muller progenitor cell expression of PDGFRalpha and ability to induce proliferative vitreoretinopathy in a rabbit model. Stem Cells Int. 2012;2012:106486.
20. Abdollahi A, Li M, Ping G, et al. Inhibition of platelet-derived growth factor signaling attenuates pulmonary fibrosis. J Exp Med. 2005;201:925-935.
21. Ikuno Y, Leong FL, Kazlauskas A. Attenuation of experimental proliferative vitreoretinopathy by inhibiting the plateletderived growth factor receptor. Invest Ophthalmol Vis Sci. 2000;41:3107-3116.
22. Lei H, Rheaume MA, Velez G, Mukai S, Kazlauskas A. Expression of PDGFRalpha is a determinant of the PVR potential of ARPE19 cells. Invest Ophthalmol Vis Sci. 2011;52: 5016-5021.
23. Yamasaki Y, Miyoshi K, Oda N, et al. Weekly dosing with the platelet-derived growth factor receptor tyrosine kinase inhibitor SU9518 significantly inhibits arterial stenosis. Circ Res. 2001;88:630-636.
24. Li M, Ping G, Plathow C, et al. Small molecule receptor tyrosine kinase inhibitor of platelet-derived growth factor signaling (SU9518) modifies radiation response in fibroblasts and endothelial cells. BMC Cancer. 2006;6:79.